Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Analyses of Minimal Residual Disease (MRD) Negativity Dynamics in the Phase 3 Imroz Study

被引:1
作者
Orlowski, Robert Z. [1 ]
Dimopoulos, Meletios-Athanasios [2 ]
Leleu, Xavier [3 ,4 ]
Liu, Zhuogang [5 ]
Ishida, Tadao [6 ]
Hajek, Roman [7 ,8 ]
Spicka, Ivan [9 ,10 ]
Romejko-Jarosinska, Joanna [11 ]
Vorobyev, Vladimir I. [12 ]
Besemer, Britta [13 ]
Besisik, Sevgi
Robak, Pawel
Goldschmidt, Hartmut [14 ]
Martin, Thomas [15 ]
Mohty, Mohamad [16 ,17 ]
Mace, Sandrine [18 ]
Kodas, Ercem [18 ]
Tekle, Christina [19 ]
Shafer, Andrea [19 ]
Moreau, Philippe [20 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[3] CHU, Serv Hematol & Therapie Cellulaire, Poitiers, France
[4] CIC, Inserm 1402, Poitiers, France
[5] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China
[6] Japanese Red Cross Med Ctr, Tokyo, Japan
[7] Univ Hosp Ostrava, Dept Hemato Oncol, Ostrava, Czech Republic
[8] Univ Ostrava, Fac Med, Ostrava, Czech Republic
[9] Charles Univ Prague, Prague, Czech Republic
[10] Gen Hosp Prague, Prague, Czech Republic
[11] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lymphoid Malignancies, Warsaw, Poland
[12] SP Botkin Moscow City Clin Hosp, Moscow, Russia
[13] Univ Hosp Tuebingen, Dept Hematol Oncol Immunol & Rheumatol, Tubingen, Germany
[14] Heidelberg Univ Hosp, Internal Med Hematol Oncol & Rheumatol 5, GMMG Studygroup, Heidelberg, Germany
[15] Univ Calif San Francisco, Dept Hematol, San Francisco, CA USA
[16] Sorbonne Univ, Hop St Antoine, Dept Hematol, Paris, France
[17] INSERM, Paris, France
[18] Sanofi, R&D, Vitry Sur Seine, France
[19] Sanofi, Cambridge, MA USA
[20] Univ Hosp Hotel Dieu, Nantes, France
关键词
D O I
10.1182/blood-2024-203818
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:772 / 772
页数:1
相关论文
empty
未找到相关数据